A market authorization allows the manufacturer of a health product to make it available to the public. This authorization is issued by Health Canada when a manufacturer presents strong scientific evidence of the safety, efficacy and quality of the health product. After receiving market authorization, the manufacturer must continue to monitor the health product and provide updates on its safety and efficacy to Health Canada at set times.
Subscribe to our newsletter!
Follow the latest news from CATALIS and Clinical Trials Quebec